Eloxx Pharmaceuticals Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-09
Category: business
Source: BioSpace (via Eloxx Pharmaceuticals, Inc.)
Original source

Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) announced the pricing of a public offering of common stock and pre-funded warrants, expecting gross proceeds of $66.0 million. The shares are anticipated to begin trading on the Nasdaq Capital Market on June 9, 2026.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai